AETHLON MEDICAL INC (39) | Uncategorized (8)

Recent Contracts

Amendment to SBIR Phase II Award Contract, by and among Aethlon Medical, Inc., the National Institutes of Health and the National Cancer Institute, dated October 28, 2020 (Filed With SEC on June 28, 2022)
At the Market Offering Agreement, dated March 24, 2022, by and between Aethlon Medical, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on March 24, 2022)
Amendment to SBIR Phase II Award Contract, effective as of July 1, 2020, by and among Aethlon Medical, Inc., the National Institutes of Health and the National Cancer Institute (Filed With SEC on November 9, 2021)
At the Market Offering Agreement, March 22, 2021, by and between Aethlon Medical, Inc. and H.C. Wainwright & CO., LLC (Filed With SEC on March 22, 2021)
Description of Aethlon Medical, Inc.s Securities (Filed With SEC on June 25, 2020)
SBIR Phase II Award Contract, effective as of September 12, 2019, by and among Aethlon Medical, Inc., the National Institutes of Health and the National Cancer Institute (Filed With SEC on November 1, 2019)
Strategic Joint Cross-Licensing Agreement, dated June 30, 2019, by and between the Registrant and SeaStar Medical, Inc (Filed With SEC on August 14, 2019)
Form of Option Grant Agreement for Officers and Directors (Filed With SEC on February 11, 2019)